20.01.2017 • NewsElaine BurridgeSQMdoj

SQM Agrees $30 Million Fine for Fake Invoice

(c) Pierre Desrosiers/Shutterstock
(c) Pierre Desrosiers/Shutterstock

Chilean chemicals and mining group SQM has agreed to pay fines amounting to more than $30 million to the US Department of Justice (DoJ) and the Securities and Exchange Commission (SEC) in connection with fake invoices.

SQM said the DoJ would defer charges relating to internal accounting failures, scrapping them after three years, if it agreed to pay nearly $15.5 million and be monitored for two years. The Chilean firm will also pay the SEC a penalty of $15 million, also relating to accounting violations.

Authorities have been investigating claims that executives at SQM, which is one of the world’s largest suppliers of iodine and lithium, had faked invoices to hide illicit donations to political campaigns from 2008 to 2015. In total, SQM admitted having paid nearly $15 million to vendors in the seven-year period despite having no evidence that any goods or services were actually received.

According to the DoJ, SQM said it had given approximately $630,000 to foundations controlled by a Chilean official with influence over the government’s mining plans in the country, a key segment of SQM’s business. In another example, SQM paid around $11,000 to the sister-in-law of a Chilean official who had submitted a false invoice to disguise payment to a senatorial campaign.

The subsequent scandal led to Patricio Contesse, who had been CEO of SQM for 25 years, being fired in March 2015.

As part of the agreement with the DoJ, SQM has agreed to continue to cooperate with the investigation, enhance its compliance program, implement rigorous internal controls and retain an independent corporate compliance monitor for two years, with a third year of self-reporting thereafter.

Because SQM did co-operate with the investigation and is implementing remedial measures, it received a 25% reduction in the low-end of the penalty range, the DoJ said.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.